Record Revenue and Historical Highs
Highest quarterly and annual revenues since 2017; Data Analytics segment achieved its highest-ever quarterly and annual revenue in company history; total company revenue grew 33% YoY in the fourth quarter.
Data Analytics Explosive Growth and Profitability
Data Analytics service revenues surged (management cited +381% versus the comparable period) and DA gross profit reached 73% in Q4 2025 versus 39% a year ago; DA gross profit contributed 48% of total company gross profit in 2025 compared with 8% in the year-ago quarter.
Large Increase in Upstream Revenues and Gross Profit
Upstream revenues expanded from $2.1 million in 2024 to over $21 million in 2025; upstream gross profit rose from $1.2 million in 2024 to $18.4 million in 2025, indicating material margin expansion in upstream analytics.
Adjusted EBITDA and Net Income Improvement
Adjusted EBITDA grew 123% year-over-year for the full year (40% growth in the quarter under the revised calculation); management indicates adjusted EBITDA near the top of original guidance. Full-year net income improved substantially (management cited a 191% improvement for 2025).
Recurring Revenue and Backlog Momentum
Exited the year with over $12.02 million per month in recurring high-margin revenue from Data Analytics deployments and a multiyear backlog providing visibility to future cash flows and margin expansion.
PowerTech Integration and Revenue Catalyst
Completed onboarding of PowerTech assets; PowerTech generated $15.8 million of revenue in 2025 and is expected to generate north of $27 million in 2026 (approximately +70% year-over-year), with the utility/disaster recovery contract incremental to that run rate.
Technology and Measurement Milestone (XBEG)
XBEG spectrometer became the first optical instrument to meet GPA 2172 custody-transfer reproducibility and repeatability requirements (10/29/2025), providing a key competitive and commercial advantage for custody-transfer and digital valuation use cases.
Chemistry Segment Resilience
Chemistry Technology revenues increased ~25% for full year 2025 versus 2024 (excluding OSP payment), despite a 24% decline in average North American frac fleet count (201 to 154) over the same period — demonstrating resilience and market share gains.
Safety and Operational Excellence
Achieved zero lost time incidents in field operations for the year; Prescriptive Chemistry Management and Raceland NTI team surpassed 10 years without a lost time incident.
Balance Sheet and Deferred Tax Recognition
Total assets rose to just over $220 million after release of valuation allowance (allowing deferred tax asset recognition); company ended the year with $5.7 million cash and $3.3 million drawn on ABL, and management expects non-cash tax adjustments to normalize forward.